Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study is to demonstrate that combined stereotactic body radiotherapy and radiofrequency ablation is safe for patients with lung tumors near central airways.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Histologically confirmed primary lung cancer, lung metastasis from another primary, or recurrent tumors in the setting of prior RFA or cryotherapy
Tumors < 2 cm from trachea or zone of proximal bronchial tree (central tumors)
Each tumor < 5 cm in size prior to treatment
Medically inoperable patients as determined at the multidisciplinary thoracic tumor board, or medically operable patients who refuse surgery
Criterion for medical inoperability include:
Modified ACOSOG Criteria for medical inoperability:
Age > 18 years old
KPS > 70
If a woman is of childbearing potential, a negative urine or serum pregnancy test must be documented.
Ability to understand and the willingness to sign a written informed consent
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
17 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal